SELMOD

Selmod is performing the research and clinical development of new anti-infective therapies to the end-of-phase 2 approval... The post-antibiotic era has become reality. The changing reimbursement options generate opportunities for our start-up. Selmod aims for business opportunity in a re-emerging market... Swiss biotech start-up developing innovative antibiotics for the treatment of life-threatening, multi-drug resistant infections.

Also known as: Selmod GmbH

VAT numbers: CHE-143.876.722

Primary location: Basel Switzerland